Gleam Bulk Drug Research Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 3 Months
About Gleam Bulk Drug Research Foundation
Gleam Bulk Drug Research Foundation (GBDRF) is a Private Not For Profit Company incorporated in India on 20 October 2020 (Four years and three months 13 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pinkalbhai Sanghavi and Pravinkumar Patel serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85300GJ2020NPL117526
-
Company No.
117526
-
Company Classification
Private Not For Profit Company
-
Incorporation Date
20 Oct 2020
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Gleam Bulk Drug Research Foundation?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pinkalbhai Sanghavi
|
Director | 20-Oct-2020 | Current |
|
Pravinkumar Patel
|
Director | 20-Oct-2020 | Current |
Financial Performance of Gleam Bulk Drug Research Foundation.
Enhance accessibility to Gleam Bulk Drug Research Foundation's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gleam Bulk Drug Research Foundation?
Unlock access to Gleam Bulk Drug Research Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Vfp Box Private LimitedPinkalbhai Sanghavi is a mutual person
-
Maxpack Federation
Pinkalbhai Sanghavi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gleam Bulk Drug Research Foundation?
Gleam Bulk Drug Research Foundation has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gleam Bulk Drug Research Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gleam Bulk Drug Research Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.